In APOE ε4 non-carriers, we found no significant association between the APOC1 polymorphism and AD, using six genetic models (allelic comparison, recessive, dominant, overdominant, homozygote comparison, and heterozygote comparison model) (Table 4). This evidence concerns the gene APOC1 and Alzheimer disease.